SPI.L Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 июнь 2024 @ 18:47):
Our systems believe the stock currently is overvalued by -0.62% compare to its pairs and should correct downwards.

Stats
Объем за сегодня	435 650
Средний объем	661 849
Рыночная капитализация	948.98M
EPS	£0.0369 ( Q4 \| 2023-12-31 )
Дата следующего отчета о доходах	( £0 ) 2024-09-11
Last Dividend	£2.10 ( 2024-05-23 )
Next Dividend	£0 ( N/A )
P/E	33.57 (Sector) 0 (Industry) 0
ATR14	£0.285 (0.12%)

AGL.L 1.82%

AMS.L -0.23%

ANCR.L 0.43%

AVO.L -9.09%

COG.L -0.65%

CREO.L 0.00%

CRW.L 0.00%

CTEC.L -1.01%

CVSG.L -0.20%

DEMG.L 6.90%

EKF.L 3.05%

EMIS.L 0.10%

FDBK.L -2.00%

IDHC.L -4.52%

IHC.L 0.00%

INHC.L -0.09%

INS.L -0.12%

MDC.L 0.10%

MGP.L 0.47%

NSCI.L 0.69%

ODX.L -5.45%

POLX.L -10.33%

RENX.L -4.35%

RUA.L 3.41%

SDI.L -0.15%

SENS.L -33.33%

SPEC.L -5.41%

SPI.L 0.21%

TLY.L 0.00%

TSTL.L 0.28%

UDG.L 0.09%

UPR.L 0.00%

YGEN.L -0.47%

Корреляция (AI algo v.1.1b): Overvalued: -0.62% £234.95 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

Объем Корреляция

Длинно: 0.10 (neutral)

Кратко: -0.60 (weak negative)

Signal:(40.894) Neutral

Spire Healthcare Group Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Spire Healthcare Group Корреляция - Валюта/Сырье

-0.15
( neutral )

-0.32
( neutral )

-0.38
( neutral )

0.36
( neutral )

0.27
( neutral )

0.06
( neutral )

Spire Healthcare Group Финансовые показатели

Annual	2023
Выручка:	£1.36B
Валовая прибыль:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2023
Выручка:	£1.36B
Валовая прибыль:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2022
Выручка:	£1.20B
Валовая прибыль:	£440.50M (36.75 %)
EPS:	£0.0214

FY	2021
Выручка:	£1.11B
Валовая прибыль:	£491.20M (44.40 %)
EPS:	£-0.0240

Financial Reports:

No articles found.

Spire Healthcare Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0.500 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£2.10 (N/A)	£0 (N/A)	£0 (N/A)

Spire Healthcare Group Dividend Information - Dividend Knight

Dividend Sustainability Score: 8.47 - good (84.72%) | Divividend Growth Potential Score: 6.43 - Stable (28.60%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£1.800	2015-06-04
Last Dividend	£2.10	2024-05-23
Next Dividend	£0	N/A
Payout Date	2024-06-21
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	£23.30	--
Avg. Dividend % Per Year	0.49%	--
Score	3.06	--
Div. Sustainability Score	8.47
Div.Growth Potential Score	6.43
Div. Directional Score	7.45	--

Next Divdend (Est)
(2024-11-05)

£2.28 Estimate 6.67 %

Dividend Stability

0.27 Very Poor

Dividend Score

3.06

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£3.80	3.15%
2020	£2.50	1.76%
2021	£0	0.00%
2022	£0	0.00%
2023	£0.500	0.22%
2024	£2.10	0.93%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
23 May 2024	£2.10	30 Nov -0001	24 May 2024	21 Jun 2024
25 May 2023	£0.500	02 Mar 2023	26 May 2023	23 Jun 2023
28 May 2020	£2.50	05 Mar 2020	28 May 2020	23 Jun 2020
14 Nov 2019	£1.300	16 Sep 2019	15 Nov 2019	10 Dec 2019
30 May 2019	£2.50	28 Feb 2019	31 May 2019	25 Jun 2019
15 Nov 2018	£1.300	18 Sep 2018	16 Nov 2018	11 Dec 2018
31 May 2018	£2.50	02 Mar 2018	01 Jun 2018	26 Jun 2018
16 Nov 2017	£1.300	14 Sep 2017	17 Nov 2017	12 Dec 2017
01 Jun 2017	£2.50	02 Mar 2017	02 Jun 2017	27 Jun 2017
17 Nov 2016	£1.300	25 Aug 2016	18 Nov 2016	13 Dec 2016
02 Jun 2016	£2.40	17 Mar 2016	03 Jun 2016	28 Jun 2016
19 Nov 2015	£1.300	21 Aug 2015	20 Nov 2015	15 Dec 2015
04 Jun 2015	£1.800	24 Mar 2015	05 Jun 2015	30 Jun 2015

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
DNA2.L	Dividend Royal	2024-04-18	Quarterly	9	16.51%	8.69
FAIR.L	Dividend Royal	2024-05-30	Quarterly	9	10.77%	8.67
MPLS.L	Dividend Royal	2024-04-11	Quarterly	7	12.84%	8.67
BGLF.L	Dividend Royal	2024-05-02	Quarterly	9	10.03%	8.50
SEPL.L	Dividend Royal	2024-05-30	Quarterly	11	10.34%	8.34
DNA3.L	Dividend Royal	2024-04-18	Quarterly	12	14.16%	8.31
DEC.L	Dividend Royal	2024-08-29	Quarterly	8	59.83%	7.91
AA4.L	Dividend Royal	2024-04-11	Quarterly	9	12.37%	7.88
IMB.L	Dividend Royal	2024-08-22	Quarterly	28	7.10%	7.51
FBH.L	Dividend Royal	2024-05-02	Annually	22	11.26%	7.46

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0201	1.500	9.60	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0119	1.200	9.60	10.00	[0 - 0.3]
returnOnEquityTTM	0.0372	1.500	-0.698	-1.047	[0.1 - 1]
payoutRatioTTM	0.0733	-1.000	9.27	-9.27	[0 - 1]
currentRatioTTM	0.691	0.800	-1.544	-1.236	[1 - 3]
quickRatioTTM	0.483	0.800	-1.867	-1.493	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.243	-0.365	[0.2 - 2]
debtRatioTTM	0.203	-1.500	6.62	-9.93	[0 - 0.6]
interestCoverageTTM	1.360	1.000	-0.607	-0.607	[3 - 30]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.286	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.627	-1.500	7.49	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.383	1.000	6.95	6.95	[0.2 - 0.8]
operatingProfitMarginTTM	0.0931	1.000	-0.138	-0.138	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.431	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	0.594	0.800	9.37	7.50	[0.5 - 2]
Total Score				8.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.66	1.000	6.60	0	[1 - 100]
returnOnEquityTTM	0.0372	2.50	-0.449	-1.047	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.286	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0.896	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
payoutRatioTTM	0.0733	1.500	9.27	-9.27	[0 - 1]
pegRatioTTM	387.54	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.82	0	[0.1 - 0.5]
Total Score				6.43

Spire Healthcare Group Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.